List of insiders holdings for Tvardi Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | CSL LTD 10% Owner |
2023-07-25 16:13:19 | 0 7,396,770 |
7,396,770 | Form 3 |
| 2 | Moller Charles Ph.D. Director |
2014-02-05 17:09:21 | 0 1,576,404 |
1,576,404 | Form 4 |
| 3 | Slagel Dean Director |
2017-07-03 17:53:00 | 0 1,064,338 |
1,064,338 | Form 4 |
| 4 | CHALMERS DEREK T President & CEO |
2021-09-09 16:48:51 | 991,405 0 |
991,405 | Form 4 |
| 5 | VOGELBAUM MARTIN Director |
2024-06-06 16:22:30 | 801,007 0 |
801,007 | Form 4 |
| 6 | Wirk Shaheen Director |
2025-04-17 18:50:13 | 6,202 702,358 |
708,560 | Form 4 |
| 7 | HALL WALLACE L JR Director |
2025-04-17 18:50:20 | 0 448,800 |
448,800 | Form 4 |
| 8 | Shiff Susan Ph.D. Director |
2024-06-06 16:24:29 | 397,085 0 |
397,085 | Form 4 |
| 9 | Ives Jeffrey L. Director |
2024-06-06 16:25:40 | 393,485 0 |
393,485 | Form 4 |
| 10 | von Moltke Lisa Director |
2024-06-06 16:26:51 | 378,009 0 |
378,009 | Form 4 |
| 11 | Alibhai Imran Nizamudin Chief Executive Officer |
2025-04-17 18:50:05 | 370,832 0 |
370,832 | Form 4 |
| 12 | Boudreau Helen M Director |
2024-06-06 16:28:07 | 345,647 0 |
345,647 | Form 4 |
| 13 | Vifor (International) Ltd Vifor Pharma Ltd. Vifor Fresenius Medical Care Renal Pharma Ltd. 10% Owner |
2025-04-16 16:15:10 | 205,465 0 |
205,465 | Form 13D |
| 14 | Menzaghi Frederique Ph.D. CHIEF SCIENTIFIC OFF,SVP-R&D |
2024-02-05 16:28:07 | 167,247 0 |
167,247 | Form 4 |
| 15 | Medve Robert Chief Medical Officer |
2014-06-19 14:24:01 | 120,000 0 |
120,000 | Form 4 |
| 16 | BAINS HARRISON M JR Director |
2023-06-05 16:31:05 | 102,399 0 |
102,399 | Form 4 |
| 17 | Conn Avi Daniel Chief Financial Officer |
2025-04-17 18:50:06 | 89,053 0 |
89,053 | Form 4 |
| 18 | Kauh John Saewook M.D. Chief Medical Officer |
2025-04-17 18:50:19 | 74,049 0 |
74,049 | Form 4 |
| 19 | Goncalves Joana CHIEF MEDICAL OFFICER |
2024-04-09 16:22:02 | 53,365 0 |
53,365 | Form 4 |
| 20 | Schoell Josef Chief Financial Officer |
2017-07-28 16:53:40 | 50,000 0 |
50,000 | Form 4 |
| 21 | ALTA BIOPHARMA PARTNERS III LP ALTA BIOPHARMA MANAGEMENT III LLC ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC CHAMPSI FARAH HURWITZ EDWARD PENHOET EDWARD 10% Owner |
2014-02-05 16:54:37 | 0 43,212 |
43,212 | Form 4 |
| 22 | Reilly Thomas Charles Chief Financial Officer |
2022-03-04 17:54:51 | 37,811 0 |
37,811 | Form 4 |
| 23 | Larson Jeffrey Leroy SVP, Research & Development |
2025-04-17 18:50:09 | 22,128 0 |
22,128 | Form 4 |
| 24 | Lewis Michael E Chief Scientific Advisor |
2017-03-10 17:21:57 | 20,000 0 |
20,000 | Form 4 |
| 25 | Shah Sujal Director |
2025-04-17 18:50:11 | 18,441 0 |
18,441 | Form 4 |
| 26 | WYZGA MICHAEL S Director |
2025-04-17 18:50:16 | 18,441 0 |
18,441 | Form 4 |
| 27 | Mohindru Mani CFO & Chief Strategy Officer |
2019-12-04 19:50:59 | 17,441 0 |
17,441 | Form 4 |
| 28 | Chen Yixin VP, Chem, Mfg and Ctrls |
2025-04-17 18:50:15 | 14,752 0 |
14,752 | Form 4 |
| 29 | O'Brien Stephen Paul Principal Accounting Officer |
2025-04-17 18:50:22 | 14,751 0 |
14,751 | Form 4 |
| 30 | Makara Richard VP, Head of Accting;Controller |
2022-06-16 17:14:11 | 13,583 0 |
13,583 | Form 4 |
| 31 | Posner Christopher PRESIDENT AND CEO |
2025-03-04 16:59:22 | 13,109 0 |
13,109 | Form 4 |
| 32 | Maynard Ryan D CHIEF FINANCIAL OFFICER |
2024-02-12 17:15:08 | 8,012 0 |
8,012 | Form 4 |
| 33 | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. |
2025-03-04 16:58:32 | 7,190 0 |
7,190 | Form 4 |
| 34 | Stauffer Joseph William Chief Medical Officer |
2018-10-19 16:34:47 | 2,000 0 |
2,000 | Form 4 |
| 35 | RHO Ventures VI LP RMV VI L.L.C. Rho Capital Partners LLC LESCHLY MARK KAIROUZ HABIB RUCH JOSHUA 10% Owner |
2022-02-14 11:35:51 | 782 0 |
782 | Form 13G |
| 36 | Smith Cynthia Director |
2025-04-17 18:11:17 | 0 0 |
0 | Form 3 |